missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ Thalidomide-4-hydroxyacetate

Catalog No. 6466100
Change view
Click to view available options
Quantity:
100 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
6466100 100 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 6466100 Supplier Tocris Bioscience™ Supplier No. 6466/100

Carboxylic acid-functionalized Thalidomide; cereblon ligand for PROTACs

Thalidomide-4-hydroxyacetate is a derivative of Thalidomide (Cat.No. 0652), commonly used as a precursor to PROTAC® that hijacks cereblon as the E3 ubiquitin ligase component. Supplied with a carboxylic acid functional handle at a position known not to significantly affect binding to cereblon, for ready conjugation to a linker/target protein ligand.

Thalidomide-4-hydroxyacetate has been recently renamed. The previous name for this product was TC E3 5031.

Please contact us for SD files of our available Degrader Building Blocks.

PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

Require a different derivative? Get in touch .

Specifications

CAS 1061605-21-7
Synonym 2-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetic acid
Quantity 100 mg
Target Degrader Building Blocks
Molecular Formula C15H12N2O7
Formula Weight 332.26
Purity 98%